215 related articles for article (PubMed ID: 21730116)
1. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
[TBL] [Abstract][Full Text] [Related]
2. The antimalarial ferroquine: from bench to clinic.
Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium vivax susceptibility to ferroquine.
Leimanis ML; Jaidee A; Sriprawat K; Kaewpongsri S; Suwanarusk R; Barends M; Phyo AP; Russell B; Renia L; Nosten F
Antimicrob Agents Chemother; 2010 May; 54(5):2228-30. PubMed ID: 20308387
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.
Barends M; Jaidee A; Khaohirun N; Singhasivanon P; Nosten F
Malar J; 2007 Jun; 6():81. PubMed ID: 17597537
[TBL] [Abstract][Full Text] [Related]
6. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
7. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.
Eyase FL; Akala HM; Johnson JD; Walsh DS
Am J Trop Med Hyg; 2011 Dec; 85(6):984-8. PubMed ID: 22144431
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.
Henry M; Briolant S; Fontaine A; Mosnier J; Baret E; Amalvict R; Fusaï T; Fraisse L; Rogier C; Pradines B
Antimicrob Agents Chemother; 2008 Aug; 52(8):2755-9. PubMed ID: 18505855
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
Price RN; Marfurt J; Chalfein F; Kenangalem E; Piera KA; Tjitra E; Anstey NM; Russell B
Antimicrob Agents Chemother; 2010 Dec; 54(12):5146-50. PubMed ID: 20876370
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
[TBL] [Abstract][Full Text] [Related]
12. Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.
Dive D; Biot C
ChemMedChem; 2008 Mar; 3(3):383-91. PubMed ID: 17806092
[No Abstract] [Full Text] [Related]
13. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia.
Mairet-Khedim M; Nardella F; Khim N; Kim S; Kloeung N; Ke S; Kauy C; Eam R; Khean C; Pellet A; Leboulleux D; Leang R; Ringwald P; Barale JC; Leroy D; Menard D; Witkowski B
J Antimicrob Chemother; 2019 Nov; 74(11):3240-3244. PubMed ID: 31518407
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
[TBL] [Abstract][Full Text] [Related]
16. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
18. Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum.
Pradines B; Fusai T; Daries W; Laloge V; Rogier C; Millet P; Panconi E; Kombila M; Parzy D
J Antimicrob Chemother; 2001 Aug; 48(2):179-84. PubMed ID: 11481286
[TBL] [Abstract][Full Text] [Related]
19. Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.
Dubar F; Khalife J; Brocard J; Dive D; Biot C
Molecules; 2008 Nov; 13(11):2900-7. PubMed ID: 19020475
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
